Erik John Ostrowski
Chief Business Officer, Senior VP, CFO & TreasurerMr. Erik John Ostrowski, MBA, serves as Chief Financial Officer, Senior Vice President, Treasurer and Chief Business Officer of Akebia Therapeutics, Inc. from June 2024. He has been Chief Financial Officer and Treasurer at AVROBIO, Inc since January 2019 and served as its Principal Accounting Officer. He serves as President and Interim Chief Executive Officer at AVROBIO, Inc. since May 01, 2023. He had been an Independent Non-Executive Director of Faron Pharmaceuticals Oy since April 22, 2022 until April 05, 2024. He served as the Chief Financial Officer of Summit Therapeutics plc from June 2014 to December 31, 2018. Mr. Ostrowski served as Vice President of Finance at Organogenesis Inc. from 2010 to 2014. Mr. Ostrowski has experience in investment banking, finance and public accounting, with a focus on the life sciences sector. He served as a Director in Leerink Swann’s healthcare investment banking group. He began his career as an accountant at PriceWaterhouseCoopers where he worked in its audit and financial advisory services practices. He earned his Master’s in Business Administration from the University of Chicago’s Booth School of Business and has a Bachelor’s of Science in accounting and economics from Babson College, where he graduated summa cum laude. He is a Certified Public Accountant in Massachusetts.
Positions
- Company NameAkebia Therapeutics, Inc.Stock CodeAKBAPositionChief Business Officer, Senior VP, CFO & TreasurerColleagues
- JPJohn P. ButlerCEO, President & Director
- AAAdrian AdamsIndependent Chairperson
- SKSteven Keith BurkeSenior VP and Chief Research & Development Officer
- RCRichard C. MalabreSenior VP & Chief Accounting Officer
- JMJustin McCueSenior VP & Chief Technology Officer
- CSCynthia SmithIndependent Director
- MWMichael W. RogersIndependent Director
- RERonald E. FriesonIndependent Director
